In the matter of compounding application filed by the Company with the Reserve Bank of India (RBI) for having foreign investment in excess of prescribed sectoral cap, Abbott India has informed that the Company has received Compounding Order dated July 31, 2025, from the Foreign Exchange Department of RBI directing the Company to pay compounding amount of Rs 2,00,000, concluding the ongoing compounding process. The Company shall be depositing the compounding amount in accordance with the Order. The closure of the compounding process will now enable the Company to receive investment from foreign institutional investors up to the prescribed limit. The disclosure as required under Regulation 30 of the Listing Regulations read with SEBI Circular on disclosure of material events/information (SEBI Circular SEBI/HO/CFD/CFD-PoD1/P/CIR/2023/123 dated July 13, 2023), with respect to the order is enclosed as Annexure A.
The above information is a part of company’s filings submitted to BSE.
